IGF::OT::IGF EFFECT OF ASPIRIN ON BIOMARKERS OF BARRETT'S ESOPHAGUS AFTER SUCCESSFUL ERADICATION OF BARRETT'S ESOPHAGUS WITH RADIOFREQUENCY ABLATION

NIH RePORTER · NIH · N01 · $2,604 · view on reporter.nih.gov ↗

Abstract

The overall objective of this task order shall be to perform a pilot clinical trial testing the effects of aspirin on biomarkers associated with risk of recurrence of BE and/or esophageal adenocarcinoma in post-ablation esophageal biopsies

Key facts

NIH application ID: 10479746
Project number: 261201200034I-P00006-26100007-1
Recipient: UNIVERSITY OF TX MD ANDERSON CAN CTR
Principal Investigator: POWEL BROWN
Activity code: N01
Funding institute: NIH
Fiscal year: 2021
Award amount: $2,604
Award type: —
Project period: 2015-06-15 → 2021-05-31